102 related articles for article (PubMed ID: 38419758)
1. An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer.
Zhao J; Wang H; Chen J; Wang C; Gong N; Zhou F; Li X; Cao Y; Zhang H; Wang W; Zheng H; Zhang C
Biochem Biophys Res Commun; 2024 Jul; 718():149931. PubMed ID: 38723415
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in combination therapy of oncolytic vaccinia virus.
Mirbahari SN; Da Silva M; Zúñiga AIM; Kooshki Zamani N; St-Laurent G; Totonchi M; Azad T
Front Immunol; 2024; 15():1272351. PubMed ID: 38558795
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects.
Fu R; Qi R; Xiong H; Lei X; Jiang Y; He J; Chen F; Zhang L; Qiu D; Chen Y; Nie M; Guo X; Zhu Y; Zhang J; Yue M; Cao J; Wang G; Que Y; Fang M; Wang Y; Chen Y; Cheng T; Ge S; Zhang J; Yuan Q; Zhang T; Xia N
Signal Transduct Target Ther; 2024 May; 9(1):118. PubMed ID: 38702343
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor models.
Umer BA; Noyce RS; Kieser Q; Favis NA; Shenouda MM; Rans KJ; Middleton J; Hitt MM; Evans DH
PLoS One; 2024; 19(3):e0298437. PubMed ID: 38498459
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the efficacy of vaccinia-based oncolytic virotherapy by inhibiting CXCR2-mediated MDSC trafficking.
Tan Z; Chiu MS; Yue M; Kwok HY; Tse MH; Wen Y; Chen B; Yang D; Zhou D; Song YQ; Man K; Chen Z
J Leukoc Biol; 2024 Mar; 115(4):633-646. PubMed ID: 38066571
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities.
Kim Y; Konda P; Murphy JP; Paulo JA; Gygi SP; Gujar S
Mol Cell Proteomics; 2022 Feb; 21(2):100182. PubMed ID: 34922008
[TBL] [Abstract][Full Text] [Related]
7. Vaccinia virus, a promising new therapeutic agent for pancreatic cancer.
Al Yaghchi C; Zhang Z; Alusi G; Lemoine NR; Wang Y
Immunotherapy; 2015; 7(12):1249-58. PubMed ID: 26595180
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models.
Ye J; Chen L; Waltermire J; Zhao J; Ren J; Guo Z; Bartlett DL; Liu Z
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473379
[TBL] [Abstract][Full Text] [Related]
9. Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus.
Zhou D; Xu W; Ding X; Guo H; Wang J; Zhao G; Zhang C; Zhang Z; Wang Z; Wang P; Lu L; Yuan M
Cancer Sci; 2024 Apr; 115(4):1129-1140. PubMed ID: 38351514
[TBL] [Abstract][Full Text] [Related]
10. An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment.
DePeaux K; Rivadeneira DB; Lontos K; Dean VG; Gunn WG; Watson MJ; Yao T; Wilfahrt D; Hinck C; Wieteska L; Thorne SH; Hinck AP; Delgoffe GM
J Exp Med; 2023 Oct; 220(10):. PubMed ID: 37552475
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials.
Taylor IP; Lopez JA
J Cancer Res Clin Oncol; 2023 Aug; 149(10):8117-8129. PubMed ID: 37031291
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Microbiota Modulates the Antitumor Effect of Oncolytic Virus Vaccines in Colorectal Cancer.
Chen X; Wang G; Qin L; Hu B; Li J
Dig Dis Sci; 2024 Apr; 69(4):1228-1241. PubMed ID: 38400885
[TBL] [Abstract][Full Text] [Related]
13. Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment.
Dempe S; Lavie M; Struyf S; Bhat R; Verbeke H; Paschek S; Berghmans N; Geibig R; Rommelaere J; Van Damme J; Dinsart C
Cancer Immunol Immunother; 2012 Nov; 61(11):2113-23. PubMed ID: 22576056
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor-associated antigen-specific IFNγ
Murakami H; Takahama S; Akita H; Kobayashi S; Masuta Y; Nagatsuka Y; Higashiguchi M; Tomokuni A; Yoshida K; Takahashi H; Doki Y; Eguchi H; Matsuura N; Yamamoto T
Front Immunol; 2024; 15():1363568. PubMed ID: 38550601
[TBL] [Abstract][Full Text] [Related]
15. Is oncolytic adenoviral-mediated immunotherapy through p53-overexpression the solution to refractory pancreatic ductal adenocarcinoma?
Harriss LJA; Stevens L; Rayner CJ; Simpson G; Annels NE; Frampton AE
Expert Rev Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38818792
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming the tumor microenvironment leverages CD8
Mistarz A; Winkler M; Battaglia S; Liu S; Hutson A; Rokita H; Gambotto A; Odunsi KO; Singh PK; McGray AJR; Wang J; Kozbor D
Mol Ther Oncolytics; 2023 Mar; 28():230-248. PubMed ID: 36875325
[TBL] [Abstract][Full Text] [Related]
17. Engineered Luminescent Oncolytic Vaccinia Virus Activation of Photodynamic-Immune Combination Therapy for Colorectal Cancer.
Ye LY; Li YS; Ge T; Liu LC; Si JX; Yang X; Fan WJ; Liu XZ; Zhang YN; Wang JW; Wang SB; Zou H; Zheng YL; Jin KT; Mao ZW; Cai Y; Mou XZ
Adv Healthc Mater; 2024 Mar; ():e2304136. PubMed ID: 38551143
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Cancer's PD1-Roadblock: When T-Cell Reinvigoration Is Not Enough.
Lander VE; DeNardo DG
Clin Cancer Res; 2024 Feb; 30(3):474-476. PubMed ID: 38038687
[TBL] [Abstract][Full Text] [Related]
19. Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8
Wei W; Tian L; Zheng X; Zhong L; Chen Y; Dong H; Zhang G; Wang S; Tong X
Oncoimmunology; 2024; 13(1):2322173. PubMed ID: 38419758
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
